Ivar Hompland

459 total citations
25 papers, 242 citations indexed

About

Ivar Hompland is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Ivar Hompland has authored 25 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 16 papers in Gastroenterology and 12 papers in Surgery. Recurrent topics in Ivar Hompland's work include Gastrointestinal Tumor Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (14 papers) and Gastrointestinal disorders and treatments (9 papers). Ivar Hompland is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (14 papers) and Gastrointestinal disorders and treatments (9 papers). Ivar Hompland collaborates with scholars based in Norway, Sweden and Finland. Ivar Hompland's co-authors include Kjetil Boye, Øyvind S. Bruland, Toto Hølmebakk, Stephan Stoldt, Kirsten Sundby Hall, Bodil Bjerkehagen, Ingvild Lobmaier, Leonardo A. Meza‐Zepeda, Anna Paioli and Alessandra Longhi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British journal of surgery.

In The Last Decade

Ivar Hompland

23 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivar Hompland Norway 8 187 154 99 55 25 25 242
J. D. Schiffman United States 3 175 0.9× 195 1.3× 106 1.1× 50 0.9× 77 3.1× 5 295
Chong-Suk Kim South Korea 14 244 1.3× 164 1.1× 160 1.6× 66 1.2× 5 0.2× 21 362
Takanori Maruo Japan 9 126 0.7× 57 0.4× 165 1.7× 34 0.6× 5 0.2× 19 245
Laura Valori Italy 6 148 0.8× 93 0.6× 48 0.5× 58 1.1× 50 2.0× 7 221
Youhei Nakamura Japan 7 70 0.4× 31 0.2× 72 0.7× 38 0.7× 10 0.4× 22 167
Kab Choong Kim South Korea 9 286 1.5× 192 1.2× 127 1.3× 169 3.1× 18 0.7× 12 363
Kaylee M. Keller Netherlands 8 62 0.3× 39 0.3× 65 0.7× 34 0.6× 21 0.8× 10 190
Hisashi Hosaka Japan 9 297 1.6× 121 0.8× 131 1.3× 213 3.9× 7 0.3× 37 428
H. Suekane Japan 11 172 0.9× 184 1.2× 204 2.1× 63 1.1× 16 0.6× 16 370
Young‐Jae Mok South Korea 9 227 1.2× 106 0.7× 157 1.6× 70 1.3× 2 0.1× 17 344

Countries citing papers authored by Ivar Hompland

Since Specialization
Citations

This map shows the geographic impact of Ivar Hompland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivar Hompland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivar Hompland more than expected).

Fields of papers citing papers by Ivar Hompland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivar Hompland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivar Hompland. The network helps show where Ivar Hompland may publish in the future.

Co-authorship network of co-authors of Ivar Hompland

This figure shows the co-authorship network connecting the top 25 collaborators of Ivar Hompland. A scholar is included among the top collaborators of Ivar Hompland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivar Hompland. Ivar Hompland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lobmaier, Ingvild, Marta Spreafico, R. Miceli, et al.. (2025). A comparison of the risk prediction models PERSARC and Sarculator in patients with localized soft tissue sarcoma of the extremities and trunk wall. ESMO Open. 10(8). 105517–105517. 1 indexed citations
2.
3.
Skovlund, Eva, et al.. (2024). Survival prediction in patients with gynecological cancer irradiated for brain metastases. Acta Oncologica. 63. 206–212.
4.
Boye, Kjetil, Ludmila Gorunova, Bastian Gunawan, et al.. (2023). Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal Tumor. JCO Precision Oncology. 7(7). e2200351–e2200351. 5 indexed citations
5.
Seidensaal, Katharina, Jakob Liermann, Sebastian Adeberg, et al.. (2022). Inoperable or incompletely resected craniofacial osteosarcoma treated by particle radiotherapy. Frontiers in Oncology. 12. 927399–927399. 2 indexed citations
6.
Boye, Kjetil, Ingvild Lobmaier, Ingeborg Taksdal, et al.. (2022). Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based study. Acta Oncologica. 61(7). 793–800. 1 indexed citations
7.
Hompland, Ivar, Kjetil Boye, Andri Papakonstantinou, et al.. (2022). Discontinuation of imatinib in patients with oligo-metastatic gastrointestinal stromal tumor who are in complete radiological remission: A prospective multicenter phase II study.. Journal of Clinical Oncology. 40(16_suppl). 11535–11535. 1 indexed citations
8.
Hølmebakk, Toto, Leonardo A. Meza‐Zepeda, Ivar Hompland, et al.. (2021). Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach. Annals of Surgical Oncology. 28(11). 6837–6845. 13 indexed citations
9.
Boye, Kjetil, Alessandra Longhi, Tormod Kyrre Guren, et al.. (2021). Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial. Cancer Immunology Immunotherapy. 70(9). 2617–2624. 65 indexed citations
10.
11.
Hompland, Ivar, et al.. (2020). Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors. SHILAP Revista de lepidopterología. 10(1). 2–2. 3 indexed citations
12.
Boye, Kjetil, Leonardo A. Meza‐Zepeda, Ivar Hompland, et al.. (2020). A comprehensive characterization of anatomical and molecular risk factors in gastric gastrointestinal stromal tumor.. Journal of Clinical Oncology. 38(15_suppl). e23522–e23522. 1 indexed citations
13.
Hompland, Ivar, et al.. (2019). Perspectives on treatment side effects in patients with metastatic gastrointestinal stromal tumour: a qualitative study. SHILAP Revista de lepidopterología. 9(1). 6–6. 10 indexed citations
14.
Hølmebakk, Toto, Bodil Bjerkehagen, Ingvild Lobmaier, et al.. (2019). Is Peritoneal Tumor Penetration of Prognostic Importance in Gastrointestinal Stromal Tumors?. Annals of Surgical Oncology. 26(13). 4730–4736. 2 indexed citations
15.
Hølmebakk, Toto, Ivar Hompland, Bodil Bjerkehagen, et al.. (2018). Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study. Annals of Surgical Oncology. 25(5). 1133–1139. 37 indexed citations
16.
Boye, Kjetil, Ivar Hompland, Øyvind S. Bruland, et al.. (2018). Genotype and risk of tumour rupture in gastrointestinal stromal tumour. British journal of surgery. 105(2). e169–e175. 21 indexed citations
17.
Hølmebakk, Toto, Bodil Bjerkehagen, Ivar Hompland, Stephan Stoldt, & Kjetil Boye. (2018). Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour. British journal of surgery. 106(4). 419–426. 28 indexed citations
18.
Hompland, Ivar, Øyvind S. Bruland, Toto Hølmebakk, et al.. (2017). Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort. Acta Oncologica. 56(10). 1317–1323. 19 indexed citations
19.
20.
Hompland, Ivar & Øyvind S. Bruland. (2015). Can Imatinib Be Safely Withdrawn in Patients with Surgically Resected Metastatic GIST?. PubMed. 35(11). 5759–65. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. D. Schiffman Breakdown of academic impact, for papers by Chong-Suk Kim Breakdown of academic impact, for papers by Takanori Maruo Breakdown of academic impact, for papers by Laura Valori Breakdown of academic impact, for papers by Youhei Nakamura Breakdown of academic impact, for papers by Kab Choong Kim Breakdown of academic impact, for papers by Kaylee M. Keller Breakdown of academic impact, for papers by Hisashi Hosaka Breakdown of academic impact, for papers by H. Suekane Breakdown of academic impact, for papers by Young‐Jae Mok
Rankless by CCL
2026